Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
about
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Predictive Factors of Lapatini ...... ve Multicenter HERLAPAC Study.
@ast
Predictive Factors of Lapatini ...... ve Multicenter HERLAPAC Study.
@en
type
label
Predictive Factors of Lapatini ...... ve Multicenter HERLAPAC Study.
@ast
Predictive Factors of Lapatini ...... ve Multicenter HERLAPAC Study.
@en
prefLabel
Predictive Factors of Lapatini ...... ve Multicenter HERLAPAC Study.
@ast
Predictive Factors of Lapatini ...... ve Multicenter HERLAPAC Study.
@en
P2093
P2860
P50
P1433
P1476
Predictive Factors of Lapatini ...... ve Multicenter HERLAPAC Study.
@en
P2093
Arianna Pellegrino
Elena Fiorio
Fabiana Marchetti
Filippo Montemurro
Giancarlo Bisagni
Gianluigi Lunardi
Giuseppe Bogina
Ida Pavese
Jennifer Foglietta
Monica Turazza
P2860
P304
P356
10.1371/JOURNAL.PONE.0156221
P407
P577
2016-05-25T00:00:00Z